𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Impact of the Food and Drug Administration’s Public Health Notification on the Adoption of Drug-Eluting Stents

✍ Scribed by Jeptha P. Curtis; David J. Cohen; Philip G. Jones; Richard G. Bach; John A. Spertus; Harlan M. Krumholz

Book ID
113443735
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
153 KB
Volume
99
Category
Article
ISSN
0002-9149

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Overview of the 2006 Food and Drug Admin
Overview of the 2006 Food and Drug Administration Circulatory System Devices Panel meeting on drug-eluting stent thrombosis
✍ Tina L. Pinto Slottow; Ron Waksman 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB 👁 1 views

## Abstract Drug‐eluting stents (DES) seemed likely to mitigate the problem of restenosis and have become the predominant stent deployed during percutaneous coronary intervention (PCI). Sustained concerns about the rate of stent thrombosis (ST), particularly very late ST (>1 year following PCI) led